Vanguard Personalized Indexing Management
NVAX icon

Vanguard Personalized Indexing Management’s Novavax NVAX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
12,638
+610
+5% +$5.47K ﹤0.01% 2026
2026
Q1 		$97.9K Buy
+12,028
New +$109K ﹤0.01% 1949
2025
Q4 		– Sell
-12,755
Closed -$111K – 2042
2025
Q3 		$111K Buy
12,755
+1,268
+11% +$9.87K ﹤0.01% 1805
2025
Q2 		$72.4K Buy
+11,487
New +$76.1K ﹤0.01% 1779
2022
Q3 		– Sell
-4,346
Closed -$224K – 1279
2022
Q2 		$224K Sell
4,346
-4,498
-51% -$233K 0.01% 1100
2022
Q1 		$651K Buy
8,844
+4,029
+84% +$359K 0.03% 691
2021
Q4 		$689K Buy
4,815
+1,348
+39% +$232K 0.04% 563
2021
Q3 		$719K Buy
3,467
+1,170
+51% +$258K 0.06% 337
2021
Q2 		$488K Buy
+2,297
New +$421K 0.05% 491

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Vanguard Personalized Indexing Management's NVAX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Novavax (NVAX) stake by 5.1% in Q2 2026, buying an estimated $5.47K and bringing the position to 12,638 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

Vanguard Personalized Indexing Management first reported a position in NVAX in Q2 2021 and has held it in 9 quarters since. The position peaked at $719K in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 12,638 shares of Novavax worth $119K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 610 Novavax shares in Q2 2026, an estimated $5.47K.
  • Novavax made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2026 holding.
  • Vanguard Personalized Indexing Management first reported a position in Novavax in Q2 2021 and has held it in 9 quarters since.
  • Vanguard Personalized Indexing Management's Novavax position peaked at $719K in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.